Laguna Niguel, CA, United States of America

Vrushali M Waknis

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vrushali M Waknis. Retrieved from https://idiyas.com/inventor/vrushali-m-waknis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Vrushali M Waknis

Introduction

Vrushali M Waknis is an accomplished inventor based in Laguna Niguel, CA (US). She has made significant contributions to the field of pharmaceutical formulations, particularly focusing on enhancing the performance of amorphous solids.

Latest Patents

One of her notable patents is titled "Enhanced performance of amorphous solid and solubilized formulations for achieving therapeutic plasma concentrations." This invention relates to solid amorphous Compound (I) having the formula (I) and to solid amorphous dispersions comprising Compound (I) and one or more polymers or to solution formulations comprising Compound (I) and one or more co-solvents and surfactants. The formulations exhibit enhanced stability and bioavailability, making them crucial for therapeutic applications.

Career Highlights

Vrushali M Waknis is currently associated with Bristol-Myers Squibb Company, where she continues to innovate in the pharmaceutical sector. Her work focuses on developing formulations that improve drug delivery and efficacy.

Collaborations

She has collaborated with notable colleagues, including Srikanth Koravady Sridhar and Jaquan Kalani Levons, to advance her research and development efforts.

Conclusion

Vrushali M Waknis is a pioneering inventor whose work in pharmaceutical formulations has the potential to significantly impact therapeutic practices. Her contributions are vital in enhancing drug stability and bioavailability.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…